Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-07 Sale |
2022-06-08 4:03 pm |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
841 | $21.89 | $18,409 | 1,840 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:49 pm |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
1,364 | $22.79 | $31,086 | 158,091 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:48 pm |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
1,483 | $22.82 | $33,842 | 1,198 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:45 pm |
FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director |
672 | $22.75 | $15,288 | 2,009 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:43 pm |
FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director |
1,439 | $22.81 | $32,824 | 57,632 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-06 4:40 pm |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
807 | $22.8 | $18,400 | 1,874 (Direct) |
View |
| 2022-06-01 Sale |
2022-06-02 4:04 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $22.96 | $574,000 | 243,361 (Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 4:11 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $34.89 | $1,395,792 | 514,038 (Direct) |
View |
| 2022-04-19 Sale |
2022-04-21 4:04 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer |
4,062 | $35.37 | $143,673 | 151,033 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-04 5:01 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $38.85 | $971,250 | 276,556 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-15 4:27 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $31.07 | $776,733 | 215,990 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-11 4:58 pm |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
31,562 | $35.02 | $1,105,200 | 159,455 (Direct) |
View |
| 2022-01-20 Sale |
2022-01-24 4:36 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $39.66 | $1,586,500 | 540,992 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:09 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
14,566 | $48.68 | $709,027 | 431,546 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:08 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
5,419 | $48.53 | $262,975 | 155,849 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:07 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
4,570 | $48.5 | $221,655 | 146,532 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:06 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,770 | $48.45 | $85,757 | 108,634 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:05 pm |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Senior VP Clinical Development |
3,965 | $48.51 | $192,340 | 121,793 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:07 pm |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
34,156 | $46.86 | $1,600,534 | 446,112 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:06 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
7,738 | $46.43 | $359,313 | 161,268 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:05 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
5,596 | $46.38 | $259,558 | 151,102 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:03 pm |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $59.34 | $2,966,853 | 235,649 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-21 4:08 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
15,977 | $60 | $958,620 | 238,642 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-09 Option Award |
2022-06-13 4:44 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | Xu Yuan Director |
20,543 | $0 | 25,287 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:43 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director |
20,543 | $0 | 629,317 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:42 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
20,543 | $0 | 178,634 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:41 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | Jooss Karin Director |
20,543 | $0 | 21,741 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:41 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director |
20,543 | $0 | 22,552 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:40 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director |
20,543 | $0 | 23,224 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:39 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director |
20,543 | $0 | 78,175 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:38 pm |
N/A 2032-06-09 |
FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director |
20,543 | $0 | 22,383 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-02 4:04 pm |
N/A 2028-01-16 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $0 | 243,361 (Direct) |
View |
| 2022-06-01 Exercise |
2022-06-02 4:04 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $6.55 | 243,361 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 4:11 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $2.7 | 514,038 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:01 pm |
N/A 2025-01-05 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
25,000 | $0 | 276,556 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
19,433 | $4.84 | 276,556 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
5,567 | $6.55 | 276,556 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-15 4:27 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $0 | 215,990 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-15 4:27 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $2.73 | 215,990 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 4:58 pm |
N/A 2022-03-12 |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
31,562 | $0 | 159,455 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-11 4:58 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director |
31,562 | $1.63 | 159,455 (Direct) |
View |
| 2022-01-20 Exercise(A) |
2022-02-04 5:59 pm |
N/A 2026-01-11 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
40,000 | $0 | 624,038 (Direct) |
View |
| 2022-01-20 Exercise(A) |
2022-02-04 5:59 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
30,000 | $2.7 | 624,038 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:38 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram See Remarks |
86,360 | $0 | 232,892 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:37 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer |
86,360 | $0 | 208,153 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:37 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Plavsic Mark Chief Technical Officer |
86,360 | $0 | 183,900 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:35 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
86,360 | $0 | 194,994 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:09 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
289,403 | $0 | 289,403 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:06 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks |
86,360 | $0 | 242,209 (Direct) |
View |
| 2021-07-01 Exercise(A) |
2022-01-27 4:04 pm |
N/A 2028-01-16 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
15,383 | $0 | 184,777 (Direct) |
View |
| 2022-01-20 Exercise |
2022-01-24 4:36 pm |
N/A 2027-01-03 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
30,000 | $2.73 | 540,992 (Direct) |
View |
| 2022-01-21 Exercise |
2022-01-24 4:36 pm |
N/A 2026-01-11 |
FATE THERAPEUTICS INC | FATE | Wolchko J Scott President and CEO |
10,000 | $2.7 | 540,992 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:03 pm |
N/A 2028-01-16 |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $0 | 235,649 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:03 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary |
50,000 | $6.55 | 235,649 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $0 | 238,642 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $35.52 | 238,642 (Direct) |
View |